Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Forsteo ® (teriparatide)
Forsteo® (Teriparatide): Recommended Treatment Duration
The recommended treatment time of 24 months should not be exceeded.
The maximum total duration of treatment with Forsteo should be 24 months. The 24-month course of Forsteo should not be repeated over a patient’s lifetime.1
Following cessation of Forsteo therapy, patients may be continued on other osteoporosis therapies.1
1. Forsteo [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
Date of Last Review: March 03, 2020